Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Radiosensitization effect of bromodomain overexpression on thyroid anaplastic tumor using human applicable low iodine-131 dose

Juri Na, Hyewon Youn, Keon Wook Kang and June-Key Chung
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1445;
Juri Na
1Department of Biomedical Sciences Seoul National University Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyewon Youn
3Cancer Imaging Center Seoul National University Hospital Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keon Wook Kang
4Department of Nuclear Medicine Seoul National University Hospital Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June-Key Chung
2Laboratory of Molecular Imaging and Therapy Seoul National University Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1445

Objectives DNA double strand breaks (DSBs) repair can enable tumor cells to overcome DNA damage after radiation therapy and this often leads to radioresistance. Radiation sensitization is required to increase therapeutic effect. Brahma-related gene 1 (BRG1), the catalytic subunit of SWI/SNF chromatin-remodeling complex, involves in DSBs repair. The BRG1 assists DSBs repair by stimulating γ-H2AX formation. DSBs repair is not completed without BRG1 binding to acetylated histones at DSBs via bromodomain (BRD). We previously reported the therapeutic effect of BRD overexpression, resulting inhibition of BRG1 binding, in case of high I-131 dose (500 μCi). However, this dose is compatible to 1,500 mCi in human being (60 kg). In this study, we investigated therapeutic effect of BRD overexpression in case of low I-131 dose (60 μCi), which is converted from clinical therapeutic dose (180 mCi) in human by their weights.

Methods FRO anaplastic thyroid cancer cells which containing a luciferase reporter gene (effluc) were transfected by optimized human sodium iodide symporter (pMSCV-oNIS) and pMX-BRG1-BRD retro-viral vector. The cell lines were divided into three groups: Control, oNIS, and oNIS+BRD expressing cell lines. Clonogenic assay, γ-H2AX foci staining, and Western blotting were conducted. Each cell lines of the three groups were subcutaneously injected into BALB/c nude mice. I-131 was treated when tumor cells reached 108 photon/sec by luminescence signal. Animal SPECT/CT imaging was also acquired to visualize I-131 uptake. To investigate the effect of BRD on I-131 therapy, tumor size was measured with caliper and tumor proliferation was measured with optical signal obtained by IVIS imaging system.

Results The results of clonogenic assay, γ-H2AX foci staining, and Western blotting indicated that radiation sensitizing effect of BRD overexpression. Survival colonies of oNIS+BRD were 12.14%, while oNIS cells survived 28.60%, and control cells survived 64.84% after I-131 therapy. Especially, the luciferase signal of oNIS tumor was 3.4 times higher than oNIS+BRD tumors. Also, the tumor size of oNIS tumor was 2.1 times higher than oNIS+BRD tumors at 6 days after treating 60 μCi of I-131.

Conclusions Radiosensitizing effect of human applicable dose (60 μCi) combined with BRD overexpression was occured. Human application of this system may be possible. We have shown that radio-sensitizing effect induced by BRG1-BRD overexpression on radioiodine therapy, and our results indicating that BRG1-BRD overexpression could be used as a therapeutic gene by combination with NIS for reducing therapeutic dose of radioiodine.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiosensitization effect of bromodomain overexpression on thyroid anaplastic tumor using human applicable low iodine-131 dose
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiosensitization effect of bromodomain overexpression on thyroid anaplastic tumor using human applicable low iodine-131 dose
Juri Na, Hyewon Youn, Keon Wook Kang, June-Key Chung
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1445;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiosensitization effect of bromodomain overexpression on thyroid anaplastic tumor using human applicable low iodine-131 dose
Juri Na, Hyewon Youn, Keon Wook Kang, June-Key Chung
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1445;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Radiopharmaceutical Therapy Posters

  • Target organ dose range-based, high-activity Zevalin®-inclusive non-myeloablative conditioning for allogeneic stem cell transplantation: a stratified approach
  • Introduction of Re-188 to enhance the inhibiting effect of Bevacizumab for Non-small-cell Lung Cancer
  • Dermatological high-dose-rate beta-brachytherapy for treatment of basal and squamous cell carcinomas and extramammary Paget's disease
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire